Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2021-08-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司关于使用部分暂时闲置募集资金进行现金管理的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 南微医学科技股份有限公司 regarding the use of temporarily idle raised funds for cash management. It details the board and supervisory approvals, investment scope, risk controls, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial data but rather describes a corporate decision and regulatory compliance related to the use of raised funds. It is not an annual or interim report, audit report, or earnings release. It is also not a proxy, voting result, or management change announcement. The document fits best as a Regulatory Filing (RNS) because it is a formal disclosure about the company's use of funds and compliance with regulations, without being a full financial report or a simple report publication announcement. The document length (3388 characters) and content support this classification.
2021-08-25 Chinese
南微医学科技股份有限公司2021年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2021 Half-Year Special Report on the Deposit and Use of Raised Funds" by 南微医学科技股份有限公司. It details the actual amount of funds raised, their deposit, usage, management, and specific investment projects during the half-year period ending June 30, 2021. The content includes detailed financial figures related to fundraising, usage of funds, and compliance with regulatory requirements. It is a specialized report focusing on the management and use of capital raised by the company, specifically for the half-year period, rather than a full annual report or a general financial statement. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is over 6,000 characters and contains substantive financial data, so it is not a mere announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2021-08-25 Chinese
南微医学科技股份有限公司董事会人才委员会工作制度
Governance Information Classification · 95% confidence The document is titled as the 'Board of Directors Talent Committee Work System' of 南微医学科技股份有限公司, detailing the establishment, composition, responsibilities, meeting rules, and operational procedures of the Board's Talent Committee. It references company laws, governance codes, and stock exchange listing rules, indicating it is a governance-related internal regulation document. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, or other report types. It is clearly a governance practice document related to board committee structure and function. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2068 characters, which is consistent with a detailed governance policy rather than a brief announcement or a full report.
2021-08-25 Chinese
南微医学科技股份有限公司关于召开2021年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of a 2021 half-year performance explanation meeting (业绩说明会) for investors, to be held online on August 27, 2021. It mentions the upcoming release of the 2021 half-year report on August 26, 2021, but does not contain any actual financial data or the report itself. The document is primarily an invitation and notice of the investor presentation meeting rather than the report or transcript itself. Given the nature of the document as a notice for an investor presentation event, the most appropriate classification is Investor Presentation (IP). The document length is short (1343 characters), and it is not a transcript or the report itself, so it is not a Call Transcript or Interim Report. Therefore, the classification is IP with high confidence.
2021-08-19 Chinese
南微医学科技股份有限公司关于第三届董事会第一次会议相关事项的独立意见
Regulatory Filings
2021-08-09 Chinese
南微医学科技股份有限公司第三届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the third Supervisory Board of the company. It details the election of the chairman of the Supervisory Board and the meeting procedures. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory certifications. The content is about board/management changes specifically related to the Supervisory Board, which falls under management or board information. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a direct announcement of a board resolution.
2021-08-09 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.